Impact of the COVID-19 crisis on imaging in oncological trials.

Christophe M DerooseFrédéric E LecouvetLaurence ColletteDaniela E Oprea-LagerWolfgang G KunzLuc BidautJoost J C VerhoeffCaroline CaramellaEgesta LopciBertrand TombalLioe-Fee de Geus-OeiLaure FournierMarion SmitsNandita M deSouza

Published in: European journal of nuclear medicine and molecular imaging (2020)

Keyphrases

coronavirus disease
sars cov
high resolution
public health
rectal cancer
radical prostatectomy
prostate cancer
robot assisted
respiratory syndrome coronavirus
fluorescence imaging